Loading
AP
Achillion Pharmaceuticals Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by FISHERMAN JASON S, was filed 23 Dec 2016.
Achillion Pharmaceuticals Inc: what insiders have been doing
Achillion Pharmaceuticals Inc is a listed company. Its directors and officers file their transactions with SEC (Form 4). The past year has been quiet: not a single insider filing for Achillion Pharmaceuticals Inc. The previous disclosure was published on 30 January 2020.
The full history, which starts in 2016, counts 6 purchases against 4 sales.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
38
Thresholds
n/a
Buy Volume
€89,635
6 ops. · all time
Sell Volume
€44M
4 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2016FY ended December 2016 · cache
Income statement
Revenue13.4M
Net income-62.6M-468.5% margin
Last declaration on 30 January 2020
Declarations38 total
10,917 shares@ US$6.300.1% of flowCommon StockSEC:0001104659-20-008815:0
14,115,498 shares@ US$6.3099.9% of flowCommon StockSEC:0001104659-20-008815:1
3,500 shares@ US$6.301.7% of flowCommon StockSEC:0001562180-20-000676:0
90,000 shares@ US$6.3088.3% of flowCommon StockSEC:0001562180-20-000670:0
1,500 shares@ US$6.301.5% of flowCommon StockSEC:0001562180-20-000670:1
2,500 shares@ US$6.30100.0% of flowCommon StockSEC:0001562180-20-000674:0
40,000 shares@ US$6.3074.7% of flowCommon StockSEC:0001562180-20-000677:0
36,431 shares@ US$6.301.1% of flowCommon StockSEC:0000904454-20-000088:0
3,393,382 shares@ US$6.3098.2% of flowCommon StockSEC:0000904454-20-000088:1
25,159 shares@ US$6.300.7% of flowCommon StockSEC:0000904454-20-000088:2
22,709 shares@ US$6.30100.0% of flowCommon StockSEC:0001562180-20-000672:0
29,515 shares@ US$6.3025.2% of flowCommon StockSEC:0001562180-20-000675:0
63,249 shares@ US$6.3054.1% of flowCommon StockSEC:0001562180-20-000675:1
20,000 shares@ US$3.2819.2% of flowCommon StockSEC:0001562180-19-006193:0
20,000 shares@ US$3.288.9% of flowCommon StockSEC:0001562180-19-005523:0
10,485 shares@ US$6.319.0% of flowCommon StockSEC:0001562180-19-005523:1
20,000 shares@ US$3.2810.2% of flowCommon StockSEC:0001562180-19-005524:0
100,234 shares@ US$3.1024.0% of flowCommon StockSEC:0001562180-19-005195:0
33,250 shares@ US$3.288.4% of flowCommon StockSEC:0001562180-19-005195:1
100,234 shares@ US$6.3749.4% of flowCommon StockSEC:0001562180-19-005195:2
33,250 shares@ US$6.3716.4% of flowCommon StockSEC:0001562180-19-005195:3
20,000 shares@ US$1.056.0% of flowCommon StockSEC:0001209191-18-063170:0
20,000 shares@ US$1.052.8% of flowCommon StockSEC:0001209191-18-063175:0
20,000 shares@ US$1.052.8% of flowCommon StockSEC:0001209191-18-036667:0
25,000 shares0Common StockSEC:0000904454-18-000397:0
25 of 38 declarations
About Achillion Pharmaceuticals Inc
Achillion Pharmaceuticals Inc is a biopharmaceutical company focused on developing treatments for viral and liver diseases. It is listed on NASDAQ under the symbol ACHN.
